Patent · US Active

Method for subtyping lymphoma types by means of expression profiling

US10607717B2 · kind B2 · utility

2Cited by
43References
3Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 5, 2014
Grant dateMar 31, 2020
Priority date
Expiry dateOct 1, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/166
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.